Related Experiment Video
Updated: Aug 14, 2026

Simultaneous Laryngopharyngeal and Conventional Esophageal pH Monitoring
Published on: December 14, 2020
Possible lansoprazole-induced eosinophilic syndrome
J D Smith1, K L Chang, J G Gums
1Department of Pharmacy Practice, University of Florida, Gainesville, USA.
This case report details a patient experiencing severe myalgia and eosinophilia after taking lansoprazole. Symptoms resolved after medication cessation, suggesting a link between lansoprazole and eosinophilic syndromes.
Area of Science:
- Gastroenterology
- Rheumatology
- Pharmacology
Background:
- Proton pump inhibitors like lansoprazole are widely used for acid-related gastrointestinal disorders.
- Eosinophilic disorders, including eosinophilia-myalgia syndrome and eosinophilic fasciitis, can present with significant musculoskeletal pain.
Observation:
- A 50-year-old woman developed severe myalgia and eosinophilia within a week of initiating lansoprazole.
- Her symptoms gradually improved after discontinuing lansoprazole and initiating prednisone therapy.
Findings:
- This case represents the first reported instance of lansoprazole-associated eosinophilic syndrome.
- The clinical presentation suggested a potential overlap between eosinophilia-myalgia syndrome and eosinophilic fasciitis.
Implications:
- This case highlights the importance of considering medication side effects, particularly lansoprazole, in patients presenting with unexplained myalgia and eosinophilia.
- It underscores the need for a broad differential diagnosis for eosinophilic disorders, recognizing potential drug-induced etiologies.
More Related Videos
03:23Three-Dimensional Cell Culture Models to Investigate the Epithelial Barrier in Eosinophilic Esophagitis
Published on: May 10, 2024
10:21Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification
Published on: September 20, 2024
Related Concept Videos
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Drugs for Treatment of Constipation-Predominant IBS
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...